$1.15
0.01991.76%
Last update: Nov 10, 12:23 PM
Sonoma Pharmaceuticals Inc
SNOANASDAQ
Sonoma Pharmaceuticals fell 69.0% from $3.65 to $1.13, behind the S&P 500's +10.5%. Its worst day was Apr 24 (−36.7%), and its low came May 19 at $1.01.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Sonoma Pharmaceuticals shares rose 12.9%, while the S&P 500 rose 0.1%.
+12.9% · S&P 500 +0.1%
Sonoma Pharmaceuticals closed at its highest level of the year, 5.2% above where the year started.
+1.1% · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
EPS of $-0.48 missed the $-0.31 estimate on $4.3M revenue (est. $4.3M).
+1.4% · S&P 500 0.0%
Sonoma Pharmaceuticals shares rose 14.1%, while the S&P 500 rose 0.8%.
+14.1% · S&P 500 +0.8%
Sonoma Pharmaceuticals shares fell 36.7%, while the S&P 500 rose 0.8%.
−36.7%, the year's worst day, on 5M shares, the year's heaviest volume · S&P 500 +0.8%
Sonoma Pharmaceuticals closed at its lowest level of the year, 72.3% below where the year started.
−1.9% · S&P 500 −0.7%
EPS of $-0.33 missed the $-0.24 estimate on $5.6M revenue (est. $5.6M).
+4.5% · S&P 500 −1.5%
EPS of $-0.09 was reported on $6.4M revenue.
+10.6% · S&P 500 −0.2%
Where it ended: a close of $1.13 on Nov 9, 2026. Up next: Q2 2027 earnings on Nov 24, 2026.
Nothing in the past 12 months.
All SNOA analyst actionsNothing in the past 12 months.
All SNOA dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SNOA and SPY from Benzinga historical bars. Not investment advice.
